Premature baby eye treatments under the microscope
NCT ID NCT07427719
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at children born prematurely who had retinopathy of prematurity (ROP), a disease that can cause blindness. Some were treated with laser, others with injections, and some had ROP but no treatment. Researchers will compare their vision and retina structure to see which approach works best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could clarify which ROP treatment better preserves vision and retinal health in premature children.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve care, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL VISUAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oslo University Hospital
Oslo, Oslo, 0424, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Checkerboard patterns may train young brains to see better
- A new window into Babies' eyes: can advanced imaging improve care for premature infants?
- App aims to shield visually impaired youth from social media's body image pitfalls
- Can a gentle eye scan replace stressful exams for preterm infants?
- Can smarter screening save premature Babies' sight?
- Can a lower dose of an eye drug protect preterm Infants' sight?